References
- Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014. Eur Heart J. 2015;36(47):3320–3331.
- Yang Z, Yang Y, Xiong K, et al. Metal-phenolic surfaces for generating therapeutic nitric oxide gas. Chem Mater. 2018;30(15):5220–5226.
- Yang Z, Yang Y, Zhang L, et al. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents. Biomaterials. 2018;178:1–10.
- Qiu H, Qi P, Liu J, et al. Biomimetic engineering endothelium-like coating on cardiovascular stent through heparin and nitric oxide-generating compound synergistic modification strategy. Biomaterials. 2019;207:10–22.
- Zhang F, Zhang Q, Li X, et al. Mussel-inspired dopamine-Cu(II) coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis. Biomaterials. 2019;194:117–129.
- Serruys PW, Chevalier B, Sotomi Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet. 2016;388(10059):2479–2491.
- Huang YH, Xu Q, Shen T, et al. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: an atherosclerotic rabbit model. Cardiol J. 2019;26(3):283–291.
- Wu X, Zhao Y, Tang C, et al. Re-endothelialization study on endovascular stents seeded by endothelial cells through up- or downregulation of VEGF. ACS Appl Mater Interfaces. 2016;8(11):7578–7589.
- Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907.
- Sonawane VC, More MP, Pandey AP, et al. Fabrication and characterization of shape memory polymers based bioabsorbable biomedical drug eluting stent. Artif Cells Nanomed Biotechnol. 2017;45(8):1740–1750.
- Jang BN, Kang SN, Eom TG, et al. Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo. J Biomed Mater Res B Appl Biomater. 2017;106(6):2275–2283.
- Hofmann D, Entrialgo-Castano M, Kratz K, et al. Knowledge-based approach towards hydrolytic degradation of polymer-based biomaterials. Adv Mater. 2009;21(32–33):3237–3245.
- He Y, Wang J, Yan W, et al. Gallic acid and gallic acid-loaded coating involved in selective regulation of platelet, endothelial and smooth muscle cell fate. RSC Adv. 2014;4(1):212–221.
- Yang J, Liu F, Tu S, et al. Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and epsilon-caprolactone. J Biomed Mater Res. 2010;94A(2):396–407.
- Chapanian R, Tse MY, Pang SC, et al. The role of oxidation and enzymatic hydrolysis on the in vivo degradation of trimethylene carbonate based photocrosslinkable elastomers. Biomaterials. 2009;30(3):295–306.
- Hou R, Wu L, Wang J, et al. Investigation on biological properties of tacrolimus-loaded poly(1,3-trimethylene carbonate) in vitro. Appl Surf Sci. 2010;256(16):5000–5005.
- Hu T, Lin S, Du R, et al. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings. Biomater Sci. 2017;5(9):1845–1857.
- Farah S. Protective layer development for enhancing stability and drug-delivery capabilities of DES surface-crystallized coatings. ACS Appl Mater Interfaces. 2018;10(10):9010–9022.
- Hafizi S, Mordi VN, Andersson KM, et al. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signaling. Vasc Pharmacol. 2004;41(4–5):167–176.
- Park DS, Park JK, Jeong MH, et al. Tacrolimus-eluting stent with biodegradable polymer is more effective than sirolimus- and everolimus-eluting stent in rabbit iliac artery restenosis model. Macromol Res. 2015;23(11):1034–1041.
- Gallo A, Mani G. A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: preparation, surface characterization, and in vitro drug release studies. Appl Surf Sci. 2013;279:216–232.
- Univers J, Long C, Tonks SA, et al. Systemic hypersensitivity reaction to endovascular stainless steel stent. J Vasc Surg. 2018;67(2):615–617.
- Nascimento JS, Barros IM, Cantarelli FL, et al. Predictors of coronary stent thrombosis: a case-control study. J Thromb Thrombolysis. 2018;46(3):420–426.
- Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016;37(15):1208–1216.
- Bakola V, Karagkiozaki V, Tsiapla AR, et al. Dipyridamole-loaded biodegradable PLA nanoplatforms as coatings for cardiovascular stents. Nanotechnology. 2018;29(27):275101.
- Raval A, Bahadur P, Raval A. Effect of nonionic surfactants in release media on accelerated in-vitro release profile of sirolimus eluting stents with biodegradable polymeric coating. J Pharm Anal. 2018;8(1):45–54.
- McMahon S, Bertollo N, Cearbhaill ED, et al. Bio-resorbable polymer stents: a review of material progress and prospects. Prog Polym Sci. 2018;83:79–96.
- Zhang J, Li M, Lu Z, et al. In vivo evaluation of stent patency by 64-slice multidetector CT coronary angiography: shall we do it or not? Int J Cardiovasc Imaging. 2012;28(3):651–658.
- Varenhorst C, Lindholm M, Sarno G, et al. Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents. Clin Res Cardiol. 2018;107(9):816–823.
- Lim KS, Park JK, Jeong MH, et al. Long-term preclinical evaluation of bioabsorbable polymer-coated drug-eluting stent in a porcine model. Macromol Res. 2017;25(7):730–738.
- Yang Z, Tu Q, Maitz MF, et al. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices. Biomaterials. 2012;33(32):7959–7971.
- Kakinoki S, Takasaki K, Mahara A, et al. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents. J Biomed Mater Res A. 2018;106(2):491–499.
- Xu X, Wang L, Wang G, et al. The effect of REDV/TiO2 coating coronary stents on in-stent restenosis and re-endothelialization. J Biomater Appl. 2017;31(6):911–922.
- Park DS, Bae IH, Jeong MH, et al. In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition. Mater Sci Eng C. 2018;91:615–623.